KCT0009595尚未招募Unknown
Aripiprazole augmentation for obsessive-compulsive symptoms of major depressive disorder: a randomized controlled trial
Chung-Ang Univerisity Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •? Age between 20 and 65 years old
- •? No prior history of antipsychotic use
- •? Y-BOCS scale score of 14 or higher, indicating moderate to severe obsessive-compulsive symptoms
- •? Have been taking a stable dose of antidepressant medication for at least 1 month
排除标准
- •? Past or present diagnosis of any other psychiatric condition by SCID-5-CV
- •? Past or present serious internal medical conditions
- •? Those with a past or present history of substance dependence or abuse
- •? Those with a history of epilepsy, head trauma, or temperamental psychiatric disorders
研究者
相似试验
招募中
3 期
Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in bipolar disorderBipolar disorder.Bipolar disorderIRCT20230814059145N1Ahvaz University of Medical Sciences46
已完成
3 期
The effect of Aripiprazole on obsessive compulsive symptomsSchizophreniaIRCT20181001041192N1Mazandaran University of Medical Sciences40
招募中
不适用
Aripiprazole augmentation for somatic symptoms of depressioKCT0004607Chung-Ang Univerisity Hospital52
已完成
不适用
Augmentation therapy with aripiprazole in selective serotonin reuptake inhibitor(SSRI)-refractory obsessive-compulsive disorder(OCD); A randomized double blind placebo controlled trialobsessive-compulsive disorderJPRN-UMIN000008743Kyushu University60
已完成
不适用
AC add on to the treatment of refractory obssessive compulsive disorder: A double-blind clinical trialObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT138806101743N2Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences72